WCN25-2173 POTENCY OF SINGLE VS DOUBLE DOSE RITUXIMAB IN DIFFICULT TO TREAT AND STEROID RESISTANT NEPHROTIC SYNDROME AMONG CHILDREN AGED 5 YEARS TO 18 YEARS

WCN25-2173 POTENCY OF SINGLE VS DOUBLE DOSE RITUXIMAB IN DIFFICULT TO TREAT AND STEROID RESISTANT NEPHROTIC SYNDROME AMONG CHILDREN AGED 5 YEARS TO 18 YEARS

Saved in:

Bibliographic Details
Main Authors:	Anjana Chari S N, DR KALAIVANI GANESAN, Dr. NEDUNCHELIAN KRISHNAMOORTHY
Format:	Article
Language:	English
Published:	Elsevier 2025-02-01
Series:	Kidney International Reports
Online Access:	http://www.sciencedirect.com/science/article/pii/S246802492403047X
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

WCN24-2688 USE OF RITUXIMAB IN STEROID SENSITIVE NEPHROTIC SYNDROME PATIENTS
by: Maia Antonella Loreti, et al.
Published: (2024-04-01)

WCN24-1037 Minimal change glomerulonephritis steroid-dependent nephrotic syndrome treated with Rituximab
by: FABRIZIO CRISTIANO
Published: (2024-04-01)

Combined Rituximab and Daratumumab Treatment in Difficult-to-Treat Nephrotic Syndrome Cases
by: Andrea Angeletti, et al.
Published: (2024-06-01)

WCN24-1789 The use of rituximab in childhood steroid-resistant nephrotic syndrome: an international, multi-centre study
by: Eugene Yu Hin Chan, et al.
Published: (2024-04-01)

Advancing the Treatment of Adult Steroid-Resistant Nephrotic Syndrome: The Role of Rituximab
by: Dmytro Ivanov, et al.
Published: (2025-03-01)

WCN25-2809 TO STUDY CALCINEURIN INHIBITOR SPARING STRATEGIES IN PATIENTS WITH STAEROID RESISTANT AND STEROID DEPENDENT NEPHROTIC SYNDROME
by: Mahak Joshi, et al.
Published: (2025-02-01)

Rituximab in young adults with steroids dependence nephrotic syndrome: a case series
by: Cecilia Baccino, et al.
Published: (2024-07-01)

WCN25-156 RITUXIMAB MAINTENANCE THERAPY IS EFFECTIVE IN MAINTAINING REMISSION IN STEROID DEPENDENT AND FREQUENT RELAPSING ADULT NEPHROTIC SYNDROME
by: Omri Feder, et al.
Published: (2025-02-01)

Long-term efficacy of Rituximab in steroid dependent and frequent relapsing adult nephrotic syndrome
by: Omri Feder, et al.
Published: (2025-03-01)

Research advances of rituximab in the treatment of children with frequent relapse or steroid-dependent nephrotic syndrome
by: Wen-jing Kang, et al.
Published: (2024-10-01)

Rituximab Administration to Treat Nephrotic Syndrome in Children: 2-Year Follow-Up
by: Dmytro Ivanov, et al.
Published: (2024-11-01)

WCN25-1329 Randomised controlled trial comparing rituximab to mycophenolate mofetil in children and young adults with steroid-dependent idiopathic nephrotic syndrome
by: Andrea Angeletti, et al.
Published: (2025-02-01)

WCN24-2162 ROLE OF RITUXIMAB IN LONG TERM REMISSION OF IDIOPATHIC STEROID DEPENDENT & FREQUENTLY RELAPSING CHILDHOOD ONSET NEPHROTIC SYNDROME
by: ARJUN RAY, et al.
Published: (2024-04-01)

Therapeutic efficacy of low-dose rituximab for steroid-dependent minimal-change nephrotic syndrome in adults
by: Li Xiao-wei, et al.
Published: (2021-01-01)

Long Term Evaluations of First Single-dose Rituximab in Children with Steroid-Dependent Minimal-Change Nephrotic Syndrome
by: Xiao-Ling Niu, et al.
Published: (2024-12-01)

Treatment of idiopathic nephrotic syndrome with two steroid dosing regimens – one-year observational study
by: Małgorzata Pańczyk-Tomaszewska, et al.
Published: (2021-10-01)

WCN24-1673 UNCOMMON CAUSE OF STEROID-RESISTANT NEPHROTIC SYNDROME, CASE REPORT
by: Sofia Victoria Sanchez Cestona, et al.
Published: (2024-04-01)

Use of urinary NGAL in steroid-resistant vs. steroid-sensitive nephrotic syndrome: a systematic review and meta-analysis
by: Aymen Abdalla, et al.
Published: (2025-08-01)

Early relapse during B lymphocyte depletion of children with frequently relapse /steroid dependent nephrotic syndrome after rituximab treatment
by: Juan Tu, et al.
Published: (2025-07-01)

Efficacy and safety of rituximab in children with steroid-dependent or frequently relapsing nephrotic syndrome: a meta-analysis of randomized controlled trials
by: Ningxin Luo, et al.
Published: (2023-02-01)

Low-dose rituximab followed by mycophenolate mofetil for steroid-dependent/frequently relapsing nephrotic syndrome in children: a case series
by: Jide Song, et al.
Published: (2025-08-01)

WCN25-4122 Rituximab in Primary Membranous Nephropathy- three years outcome
by: Prabjot Kaur Johal, et al.
Published: (2025-02-01)

Efficacy and Safety of Subcutaneous Rituximab in Idiopathic Nephrotic Syndrome
by: Paolo Cravedi, et al.
Published: (2024-11-01)

WCN24-1772 HISTOPATHOLOGICAL CHARACTERISTICS IN CHILDREN WITH MONOGENIC AND NON-GENETIC STEROID-RESISTANT NEPHROTIC SYNDROME
by: Larisa Prikhodina, et al.
Published: (2024-04-01)

WCN25-4383 EMPHYSEMATOUS PYELONEPHRITIS---A SEVEN YEAR EXPERIENCE
by: S. Vigneshwaran, et al.
Published: (2025-02-01)

Steroid-sensitive nephrotic syndrome: Do children with early onset of <4 years of age, really need standard therapy?
by: Kriti Mohan, et al.
Published: (2025-06-01)

WCN24-1148 A NOVEL MUTATION AT C.1993C>T IN EXON 16 OF THE DAAM2 GENE CAUSING STEROID RESISTANT NEPHROTIC SYNDROME ACHIEVING LONG TERM REMISSION FOLLOWING RITUXIMAB THERAPY
by: Randula Ranawaka, et al.
Published: (2024-04-01)

Early Rituximab as an Add-On Therapy in Children With the Initial Episode of Nephrotic Syndrome
by: Jialu Liu, et al.
Published: (2024-05-01)

A meta-analysis of the efficacy of rituximab in the treatment of refractory nephrotic syndrome
by: Liu Wu, et al.
Published: (2021-01-01)

WCN25-2454 ROLE OF SERUM NEPHRIN LEVELS IN ASSESSING RESPONSE TO STEROID THERAPY IN CHILDREN WITH IDIOPATHIC NEPHROTIC SYNDROME
by: Lesa Dawman, et al.
Published: (2025-02-01)

Unveiling Bifurcated Blue Straggler Sequences in NGC 2173: Insights from Binary Evolution
by: Li Wang, et al.
Published: (2025-01-01)

The efficacy and dynamic changes of immune function of rituximab with mycophenolate mofetil in the treatment of steroid-dependent /frequently relapsing nephrotic syndrome: a retrospective follow-up study
by: Songlei Gu, et al.
Published: (2025-04-01)

Rituximab versus tacrolimus as corticosteroid-sparing therapy for children with steroid-dependent nephrotic syndrome: A systematic review and meta-analysis of randomized and nonrandomized controlled trials
by: Jessica Felicia Ang, et al.
Published: (2024-04-01)

WCN25-4408 Clinical Outcomes of FSGS with Nephrotic Syndrome at 1-Year: Findings from the ITANGIBLE Registry
by: Kavita Yadav, et al.
Published: (2025-02-01)

Difficult-to-Treat Nephrotic Syndrome in Childhood–Global Depletion of B-Cells
by: Lutz T. Weber, et al.
Published: (2024-07-01)

WCN25-884 EVALUATION OF ONE YEAR OUTCOMES OF RENAL TRANSPLANT RECIPIENTS OF EXPANDED CRITERIA LIVING DONOR
by: HARDIK BAHEDIYA, et al.
Published: (2025-02-01)

Steroid-induced cataract and glaucoma in pediatric patients with nephrotic syndrome
by: Lee Ryan N. Olonan, MD, et al.
Published: (2009-12-01)

Treatment of Nephrotic Syndrome With Antinephrin Antibodies Using Plasmapheresis, Rituximab, and Mycophenolate Mofetil
by: Keiichi Takizawa, et al.
Published: (2025-05-01)

Kinetics of Rituximab Excretion into Urine and Peritoneal Fluid in Two Patients with Nephrotic Syndrome
by: Klaus Stahl, et al.
Published: (2017-01-01)

Rituximab treatment for refractory nephrotic syndrome in adults: a multicenter retrospective study
by: Xiaoyan Ma, et al.
Published: (2023-12-01)